These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2998395)

  • 1. Dose-dependent reduction of lipopolysaccharide pyrogenicity by polymyxin B.
    Warner SJ; Mitchell D; Savage N; McClain E
    Biochem Pharmacol; 1985 Nov; 34(22):3995-8. PubMed ID: 2998395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogenic response of mouse spleen cells and gelation of limulus lysate by lipopolysaccharide of Yersinia pestis and evidence for neutralization of lipopolysaccharide by polymyxin B.
    Butler T; Möller G
    Infect Immun; 1977 Nov; 18(2):400-4. PubMed ID: 200563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on the antipyretic action of polymyxin B in pyrogen-induced fever.
    van Miert AS; van Duin CT
    Arzneimittelforschung; 1978; 28(12):2246-51. PubMed ID: 227419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of polymyxin B-mediated lysis of lipopolysaccharide-treated erythrocytes.
    Carr C; Morrison DC
    Infect Immun; 1985 Jul; 49(1):84-9. PubMed ID: 2989182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation by polymyxin B of the endotoxin-mediated interferon production in the rabbit.
    Jandejsek J; Sourek J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 May; 259(3):390-6. PubMed ID: 2413651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production.
    Duff GW; Atkins E
    J Immunol Methods; 1982 Aug; 52(3):333-40. PubMed ID: 6290568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of lipopolysaccharide-induced bone resorption by polymyxin B.
    Harvey W; Wilson M; Meghji S
    Br J Exp Pathol; 1986 Oct; 67(5):699-705. PubMed ID: 3024692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lipopolysaccharide-induced TNF-alpha production by semisynthetic polymyxin-B conjugated dextran.
    Coyne CP; Moritz JT; Fenwick BW
    Biotechnol Ther; 1994-1995; 5(3-4):137-62. PubMed ID: 8608324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxin B suppresses the endotoxin inhibition of concanavalin a-mediated erythrocyte agglutination.
    Warren JR
    Infect Immun; 1982 Feb; 35(2):594-9. PubMed ID: 6276306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. II. Complement activating property of the lipopolysaccharide portion and the inhibition by polymyxin B.
    Inada K
    Jpn J Exp Med; 1980 Apr; 50(2):107-15. PubMed ID: 6256561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B.
    Jacobs DM; Morrison DC
    J Immunol; 1977 Jan; 118(1):21-7. PubMed ID: 187699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of polymyxin B with lipopolysaccharide-containing membranes.
    Goode A; Yeh V; Bonev BB
    Faraday Discuss; 2021 Dec; 232(0):317-329. PubMed ID: 34550139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyxin-B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent upon the LPS origin.
    Cavaillon JM; Haeffner-Cavaillon N
    Mol Immunol; 1986 Sep; 23(9):965-9. PubMed ID: 3023974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic polymyxin arranges lipopolysaccharide into crystalline structures to solidify the bacterial membrane.
    Manioglu S; Modaresi SM; Ritzmann N; Thoma J; Overall SA; Harms A; Upert G; Luther A; Barnes AB; Obrecht D; Müller DJ; Hiller S
    Nat Commun; 2022 Oct; 13(1):6195. PubMed ID: 36271003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyxin B inactivation of lipopolysaccharide in vaccines of Gram-negative bacteria.
    Cooperstock M; Riegle L
    Infect Immun; 1981 Jul; 33(1):315-8. PubMed ID: 6266967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrastructural study of lipopolysaccharide and of polymyxin B-induced changes of the outer membrane of Serratia marcescens (author's transl)].
    Acker G
    Zentralbl Bakteriol Orig A; 1977 Oct; 239(2):213-30. PubMed ID: 201129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and electrophoretic changes induced by polymyxin B on outer membrane components from Serratia marcescens.
    Brown DA; Tsang JC
    J Antibiot (Tokyo); 1978 Jun; 31(6):603-9. PubMed ID: 210151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of polymyxin B on outer membranes of Serratia marcescens: morphological alterations of the outer membranes and their lipopolysaccharide components.
    Weber DA; Nadakavukaren MJ; Tsang JC
    Microbios; 1976; 17(68-69):149-61. PubMed ID: 200827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The histamine-liberating action of polymyxin B and its analogs].
    Bairamashvili DI; Voĭtenko VG; Gushchin IS; Zinchenko AA; Miroshnikov AI
    Biull Eksp Biol Med; 1989 Apr; 107(4):447-9. PubMed ID: 2470441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of polymyxins on the lipopolysaccharide-defective mutants of Proteus mirabilis.
    Kaca W; Radziejewska-Lebrecht J; Bhat UR
    Microbios; 1990; 61(246):23-32. PubMed ID: 2156134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.